These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7883023)

  • 1. Oxidized lipoprotein(a) inhibits endothelium-dependent dilation: prevention by high density lipoprotein.
    Galle J; Bengen J; Schollmeyer P; Wanner C
    Eur J Pharmacol; 1994 Nov; 265(1-2):111-5. PubMed ID: 7883023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein.
    Galle J; Ochslen M; Schollmeyer P; Wanner C
    Hypertension; 1994 May; 23(5):556-64. PubMed ID: 8175161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals.
    Galle J; Bengen J; Schollmeyer P; Wanner C
    Circulation; 1995 Sep; 92(6):1582-9. PubMed ID: 7664444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High density lipoprotein and low density lipoprotein attenuate the inhibitory effects of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y
    Kobe J Med Sci; 1993 Feb; 39(1):1-14. PubMed ID: 8366661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation.
    Matsuda Y; Hirata K; Inoue N; Suematsu M; Kawashima S; Akita H; Yokoyama M
    Circ Res; 1993 May; 72(5):1103-9. PubMed ID: 8477522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine and oxidized lipoproteins affect vascular reactivity. Influence of the endothelium.
    Galle J; Schenck I; Schollmeyer P; Wanner C
    Hypertension; 1993 Mar; 21(3):315-21. PubMed ID: 8478041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin and oxidized low density lipoproteins synergistically potentiate vasoconstriction: influence of the endothelium.
    Galle J; Schollmeyer P; Wanner C
    Eur Heart J; 1993 Nov; 14 Suppl I():111-7. PubMed ID: 8293762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide.
    Tanner FC; Noll G; Boulanger CM; Lüscher TF
    Circulation; 1991 Jun; 83(6):2012-20. PubMed ID: 2040054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impairment of endothelial function induced by glyc-oxidized lipoprotein a [Lp(a)].
    Galle J; Winner B; Conzelmann E; Wanner C
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1035-45. PubMed ID: 9846885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of native and oxidized low-density lipoproteins on endothelium-dependent and endothelium-independent vasomotion.
    Galle J; Bassenge E
    Basic Res Cardiol; 1991; 86 Suppl 2():127-42. PubMed ID: 1953605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein inhibits endothelium-dependent vasodilation by an antioxidant-sensitive, lysophosphatidylcholine-independent mechanism.
    Chan H; Lougheed M; Laher I; Steinbrecher UP
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):856-65. PubMed ID: 12775962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit.
    Matthys KE; Van Hove CE; Kockx MM; Andries LJ; Van Osselaer N; Herman AG; Bult H
    Cardiovasc Res; 1998 Jan; 37(1):239-46. PubMed ID: 9539879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress.
    Galle J; Schneider R; Winner B; Lehmann-Bodem C; Schinzel R; Münch G; Conzelmann E; Wanner C
    Atherosclerosis; 1998 May; 138(1):65-77. PubMed ID: 9678772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries.
    Zhang Y; Zhang W; Edvinsson L; Xu CB
    Eur J Pharmacol; 2014 Feb; 725():10-7. PubMed ID: 24444440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.
    Galle J; Mülsch A; Busse R; Bassenge E
    Arterioscler Thromb; 1991; 11(1):198-203. PubMed ID: 1987998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious effect of glycation on the ability of HDL to counteract the inhibitory effect of oxidized LDL on endothelium-dependent vasorelaxation.
    Brindisi MC; Duvillard L; Monier S; Vergès B; Perségol L
    Diabetes Metab Res Rev; 2013 Nov; 29(8):618-23. PubMed ID: 23908137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation.
    Perségol L; Vergès B; Foissac M; Gambert P; Duvillard L
    Diabetologia; 2006 Jun; 49(6):1380-6. PubMed ID: 16596357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do triglyceride and low-density lipoprotein blood levels affect the vascular response to cyclosporine?
    Carrier M; Thai P; Stewart D; Pelletier LC
    Transplant Proc; 1994 Oct; 26(5):2639-41. PubMed ID: 7940823
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Reversal of the effect of oxidized low-density lipoproteins by high-density lipoproteins and L-arginine.
    Mehta JL; Bryant JL; Mehta P
    Biochem Pharmacol; 1995 Oct; 50(8):1181-5. PubMed ID: 7488232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.